# FDA Inspection 1122743 - Interstate Blood Bank Inc of Missouri - February 12, 2020

Source: https://www.keypedia.com/records/fda_inspections/interstate-blood-bank-inc-of-missouri/ca8b422c-0aa2-4509-a9e8-a573a67675d0
Source feed: FDA_Inspections

> FDA Inspection 1122743 for Interstate Blood Bank Inc of Missouri on February 12, 2020. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1122743
- Company Name: Interstate Blood Bank Inc of Missouri
- Inspection Date: 2020-02-12
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 999602 - 2017-01-25](https://www.keypedia.com/records/fda_inspections/interstate-blood-bank-inc-of-missouri/9c385acc-4732-4242-bd2a-8c2188b497f6)
- [FDA Inspection 864194 - 2014-01-09](https://www.keypedia.com/records/fda_inspections/interstate-blood-bank-inc-of-missouri/9d36ea9c-68b3-4234-a91a-535f9fd10ee8)
- [FDA Inspection 648133 - 2010-02-10](https://www.keypedia.com/records/fda_inspections/interstate-blood-bank-inc-of-missouri/c0e22a50-0187-4e72-a801-679b696c0153)

Company: https://www.keypedia.com/companies/interstate-blood-bank-inc-of-missouri/8e5e6326-a6cc-4ead-a646-aa733de8e91b

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d